Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.4.2 and removed older admin notices (lapse in government funding and Revision: v3.4.1); these changes are administrative and do not affect study details, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page now shows a government funding lapse notice with operating status information and a new revision tag (v3.4.1) replacing the previous v3.4.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoChange DetectedGlossary display option added; QC metadata updated to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while older QC field (Last Update Submitted that met QC Criteria) and v3.3.4 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check33 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a metadata version update rather than a change to the study content or displayed data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a Locations section with Massachusetts, Minnesota, and Utah, and removed the separate location subsections for these states. Page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page's revision indicator was updated: added Revision v3.3.2 and removed Revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.